Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Reexamination Certificate
2008-09-02
2008-09-02
Shameem, Golam M (Department: 1626)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
C548S301700, C548S302700, C548S304400, C548S309400, C514S385000, C514S393000
Reexamination Certificate
active
11290028
ABSTRACT:
Compounds represented by Formula (I):or a pharmaceutically acceptable salt or N-oxide thereof, are useful in the treatment of tumors. Combinatorial libraries composed of compounds represented by Formula (I) or benzimidazole compounds represented by Formula (II):are useful in providing compounds to assay for such therapeutically useful compounds.
REFERENCES:
patent: 3951920 (1976-04-01), Senoo
patent: 4975435 (1990-12-01), Campbell
patent: 5118688 (1992-06-01), Campbell
patent: 5563143 (1996-10-01), Cohan
patent: 5688809 (1997-11-01), Macor
patent: 5814651 (1998-09-01), Duplantier
patent: 5972980 (1999-10-01), Cornicelli
patent: 6001866 (1999-12-01), Cornicelli
patent: 6087380 (2000-07-01), Hauel
patent: 6162804 (2000-12-01), Bilodeau
patent: 6218388 (2001-04-01), Boshelli
patent: 6316474 (2001-11-01), McCauley
patent: 6326379 (2001-12-01), Macor
patent: 6329383 (2001-12-01), Hedgecock
patent: 6348474 (2002-02-01), Kayakiri
patent: 6414008 (2002-07-01), Hauel
patent: 6444617 (2002-09-01), Takaishi
patent: 6465484 (2002-10-01), Bilodeau
patent: 6469039 (2002-10-01), Hauel
patent: 6479508 (2002-11-01), Beaulieu
patent: 6512000 (2003-01-01), Anderskewitz
patent: 6534503 (2003-03-01), Dines
patent: 6534535 (2003-03-01), Zhu
patent: 6548548 (2003-04-01), Campbell
patent: 6558893 (2003-05-01), Parton
patent: 6583169 (2003-06-01), Horvath
patent: 7067662 (2006-06-01), Medina
patent: 7329684 (2008-02-01), Mjalli
patent: 7335653 (2008-02-01), Ungashe
patent: 2002/0019395 (2002-02-01), Zhu
patent: 2002/0128232 (2002-09-01), Henderson
patent: 2003/0109714 (2003-06-01), Wishart
patent: 2005/0209176 (2005-09-01), Meutermans
patent: 0 846 689 (2004-01-01), None
patent: WO 00/76501 (2001-12-01), None
patent: WO 02/059118 (2002-08-01), None
Ma Y et al. (2004), “Combinatorial Synthesis of Substituted Biaryls and Heterocyclic Arylamines”, Journal of Combinatorial Chemistry, vol. 6, No. 3, pp. 426-430.
Salvino J M et al. (2000), “Polymer-Supported Tetrafluorophenol: A New Activated Resin For Chemical Library Synthesis”, Journal of Combinatorial Chemistry, vol. 2, No. 6, pp. 691-697.
Vourloumis D et al. (2003), “Solid-phase Synthesis of Benzimidazole Libraries Biased for RNA Targets”, Tetrahedron Letters, vol. 44, No. 14, pp. 2807-2811.
Yan, Bing et al. (2003), “Quality Control in Combinatorial Chemistry: Determination of the Quantity, Purity, and Quantitative Purity of Compounds in Combinatorial Libraries”, Journal of Combinatorial Chemistry, 5 (5), pp. 547-559.
International Search Report in PCT/US2005/043114.
International Preliminary Report on Patentability and Written Opinion in PCT/US2005/043114.
Cox Matthew
Crew Andrew Philip
Laufer Radoslaw
Pegg Neil Anthony
Sambrook Smith Colin Peter
OSI Pharmaceuticals, Inc.
Shameem Golam M
LandOfFree
N-substituted benzimidazoyl c-Kit inhibitors and... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with N-substituted benzimidazoyl c-Kit inhibitors and..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and N-substituted benzimidazoyl c-Kit inhibitors and... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3931712